Trama Annalisa

Fondazione IRCCS Istituto Nazionale dei Tumori

Italy

Research Interests

Explore related searches

Professors in Italy

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

Articles (15)

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Collaborators (14)

Giovanni Maifredi

ITALY

View details

Javier Martín-Broto

SPAIN

View details

Luca Bergamaschi

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

rosalia ragusa

Professor

University of Catania

ITALY

View details

Roberto Lillini

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Antonio Giampiero Russo

Adjunct Professor

University of Milan

ITALY

View details

Damien Bennett

The Queen's University Belfast

UNITED KINGDOM

View details

Josepa Ribes Puig

Catalan Institute of Oncology

SPAIN

View details

Serena Di Cosimo

Open University

UNITED KINGDOM

View details

Rafael Marcos-Gragera

Catalan Institute of Oncology

SPAIN

View details

Stefano Cavalieri

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Yolande Lievens

Associate Professor Radiation Oncology

UGent

BELGIUM

View details

Alice Bernasconi

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

Claudia Sangalli

Fondazione IRCCS Istituto Nazionale dei Tumori

ITALY

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Trama Annalisa

Research Interests

Explore related searches

Contact this professor

Articles (15)

Comparative analysis of 5-year relative survival in adolescents and young adults with cancer relative to both children and adults in Europe (EUROCARE-6): Results from a population-based study.

Long-term survival for myeloid neoplasms and national health expenditure: a EUROCARE-6 retrospective, population-based study

Towards a better registration of neuroendocrine neoplasms: The results of the Italian retrospective population-based study

Being diagnosed with a rhabdomyosarcoma in the era of artificial intelligence: Whom can we trust?

A causal network model to estimate the cardiotoxic effect of oncological treatments in young breast cancer survivors

Developing a comorbidity score in cancer patients using healthcare utilization databases during the COVID‐19 pandemic: An experience from Italy

The observational clinical registry (cohort design) of the European Reference Network on Rare Adult Solid Cancers: The protocol for the rare head and neck cancers

Cancer treatment data available in European cancer registries: Where are we and where are we going?

Increased incidence of rare cancers and varied age distributions by cancer group: A population-based cancer registry study in Hiroshima Prefecture, Japan.

COVID‐19 outbreak in Lombardy: Impact on reducing solid cancer diagnoses in 2020

Late mortality reduction among survivors of germ cell tumors in childhood and adolescence in Europe: A report from the PanCareSurFup cohort

Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study

Best clinical management of tenosynovial giant cell tumour (TGCT): A consensus paper from the community of experts.

Is rare cancer care organized at national health system level? Multiple case study in six EU countries

Editorial: Real-World evidence in onco-hematological patients.

Collaborators (14)

Giovanni Maifredi

Javier Martín-Broto

Luca Bergamaschi

rosalia ragusa

Roberto Lillini

Antonio Giampiero Russo

Damien Bennett

Josepa Ribes Puig

Serena Di Cosimo

Rafael Marcos-Gragera

Stefano Cavalieri

Yolande Lievens

Alice Bernasconi

Claudia Sangalli

Make your next move.